Ultralife Corp. (ULBI) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts ULBI Hot Sheet
Price: $5.65 +0.36%
Financial Fact:
Net income (loss): 1.02M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Net income (loss): 1.02M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $17.3 million.
For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip
- Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
